A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the optimal time for myocardial perfusion
imaging with Technetium Tc99m Sestamibi following the administration of BMS068645. The safety
of BMS068645 will also be studied.